OpenURL Connection Search

Select item for more details and to access through your institution.

Correction to: Efficacy and safety of anti‑PD‑1/PD‑L1‑based dual immunotherapies versus PD‑1/PD‑L1 inhibitor alone in patients with advanced solid tumor: a systematic review and meta‑analysis.
Published in:
2024
By:
- Chen, Yueying;
- Han, Hedong;
- Cheng, Jing;
- Cheng, Qinpei;
- Zhu, Suhua;
- Zhan, Ping;
- Liu, Hongbing;
- Song, ·Yong;
- Lv, Tangfeng
Publication type:
Correction Notice
Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03852-w
By:
- Kim, Hye In;
- Kim, Won Gu;
- Kim, Mijin;
- Ko, Nak Gyeong;
- Jin, Mihyeon;
- Jung, Hyun Ae;
- Sun, Jong-Mu;
- Ahn, Jin Seok;
- Ahn, Myung-Ju;
- Choi, Yoon-La;
- Jeon, Min Ji;
- Kim, Tae Yong;
- Kim, Won Bae;
- Kim, Sang-We;
- Lee, Dae Ho;
- Jang, Se Jin;
- Kim, Sun Wook;
- Chung, Jae Hoon;
- Kim, Tae Hyuk;
- Lee, Se-Hoon
Publication type:
Article
Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03852-w
By:
- Kim, Hye In;
- Kim, Won Gu;
- Kim, Mijin;
- Ko, Nak Gyeong;
- Jin, Mihyeon;
- Jung, Hyun Ae;
- Sun, Jong-Mu;
- Ahn, Jin Seok;
- Ahn, Myung-Ju;
- Choi, Yoon-La;
- Jeon, Min Ji;
- Kim, Tae Yong;
- Kim, Won Bae;
- Kim, Sang-We;
- Lee, Dae Ho;
- Jang, Se Jin;
- Kim, Sun Wook;
- Chung, Jae Hoon;
- Kim, Tae Hyuk;
- Lee, Se-Hoon
Publication type:
Article
Efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: a systematic review and network meta-analysis.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03844-w
By:
- Han, Yuelin;
- Xiao, Xiangtian;
- Qin, Tingting;
- Yao, Shuxi;
- Liu, Xinyue;
- Feng, Yanqi;
- Li, Zhou;
- Li, Yiming;
- Xia, Shu
Publication type:
Article
Efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: a systematic review and network meta-analysis.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03844-w
By:
- Han, Yuelin;
- Xiao, Xiangtian;
- Qin, Tingting;
- Yao, Shuxi;
- Liu, Xinyue;
- Feng, Yanqi;
- Li, Zhou;
- Li, Yiming;
- Xia, Shu
Publication type:
Article
Optimizing cancer classification: a hybrid RDO-XGBoost approach for feature selection and predictive insights.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03843-x
By:
- Yaqoob, Abrar;
- Verma, Navneet Kumar;
- Aziz, Rabia Musheer;
- Shah, Mohd Asif
Publication type:
Article
Optimizing cancer classification: a hybrid RDO-XGBoost approach for feature selection and predictive insights.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03843-x
By:
- Yaqoob, Abrar;
- Verma, Navneet Kumar;
- Aziz, Rabia Musheer;
- Shah, Mohd Asif
Publication type:
Article
Integrative analyses of bulk and single-cell RNA-seq reveals the correlation between SPP1+ macrophages and resistance to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03848-6
By:
- Geng, Zhenyang;
- Li, Feng;
- Yang, Zhichang;
- Li, Bowen;
- Xu, Yifan;
- Wu, Bin;
- Sheng, Yinliang;
- Yuan, Ping;
- Huang, Lan;
- Qi, Yu
Publication type:
Article
Integrative analyses of bulk and single-cell RNA-seq reveals the correlation between SPP1+ macrophages and resistance to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03848-6
By:
- Geng, Zhenyang;
- Li, Feng;
- Yang, Zhichang;
- Li, Bowen;
- Xu, Yifan;
- Wu, Bin;
- Sheng, Yinliang;
- Yuan, Ping;
- Huang, Lan;
- Qi, Yu
Publication type:
Article
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03803-5
By:
- Gradone, Allison L.;
- Ma, Vincent T.;
- Vasbinder, Alexi;
- Fecher, Leslie A.;
- Yentz, Sarah;
- Hayek, Salim S.;
- Lao, Christopher D.
Publication type:
Article
Correction to: Development of nomograms to predict therapeutic response and prognosis of non-small cell lung cancer patients treated with anti-PD-1 antibody.
Published in:
2024
By:
- Yuan, Shijin;
- Xia, Yan;
- Shen, Lihong;
- Ye, Liuqing;
- Li, Lisha;
- Chen, Lifen;
- Xie, Xinyou;
- Lou, Haizhou;
- Zhang, Jun
Publication type:
Correction Notice
Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03808-0
By:
- Tachi, Tetsuro;
- Kijima, Noriyuki;
- Kuroda, Hideki;
- Ikeda, Syunya;
- Murakami, Koki;
- Nakagawa, Tomoyoshi;
- Yaga, Moto;
- Nakagawa, Kanji;
- Utsugi, Reina;
- Hirayama, Ryuichi;
- Okita, Yoshiko;
- Kagawa, Naoki;
- Kishima, Haruhiko;
- Imai, Chihaya;
- Hosen, Naoki
Publication type:
Article
Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03808-0
By:
- Tachi, Tetsuro;
- Kijima, Noriyuki;
- Kuroda, Hideki;
- Ikeda, Syunya;
- Murakami, Koki;
- Nakagawa, Tomoyoshi;
- Yaga, Moto;
- Nakagawa, Kanji;
- Utsugi, Reina;
- Hirayama, Ryuichi;
- Okita, Yoshiko;
- Kagawa, Naoki;
- Kishima, Haruhiko;
- Imai, Chihaya;
- Hosen, Naoki
Publication type:
Article
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03803-5
By:
- Gradone, Allison L.;
- Ma, Vincent T.;
- Vasbinder, Alexi;
- Fecher, Leslie A.;
- Yentz, Sarah;
- Hayek, Salim S.;
- Lao, Christopher D.
Publication type:
Article
Correction to: Development of nomograms to predict therapeutic response and prognosis of non-small cell lung cancer patients treated with anti-PD-1 antibody.
Published in:
2024
By:
- Yuan, Shijin;
- Xia, Yan;
- Shen, Lihong;
- Ye, Liuqing;
- Li, Lisha;
- Chen, Lifen;
- Xie, Xinyou;
- Lou, Haizhou;
- Zhang, Jun
Publication type:
Correction Notice
Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget's disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget's disease patients.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03846-8
By:
- Yang, Jiawen;
- Chen, Yurong;
- Zhang, Xiuyuan;
- Tong, Ziyan;
- Weng, Shanshan;
- Zhu, Ning;
- Yuan, Ying
Publication type:
Article
Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03842-y
By:
- Reimann, Patrick;
- Mavroeidi, Ilektra-Antonia;
- Burghofer, Jonathan;
- Taghizadeh, Hossein;
- Webersinke, Gerald;
- Kasper, Stefan;
- Schreil, Georg;
- Morariu, Darius;
- Reichinger, Andreas;
- Baba, Hideo Andreas;
- Kirchweger, Patrick;
- Schuler, Martin;
- Djanani, Angela;
- Prager, Gerald W.;
- Rumpold, Holger;
- Benda, Magdalena;
- Schneider, Eva-Maria;
- Mink, Sylvia;
- Winder, Thomas;
- Doleschal, Bernhard
Publication type:
Article
Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world study.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03841-z
By:
- Wang, Shanshan;
- Chao, Jiashuo;
- Wang, Hao;
- Li, Shuofeng;
- Wang, Yunchao;
- Zhu, Chengpei;
- Zhang, Nan;
- Piao, Mingjian;
- Yang, Xu;
- Liu, Kai;
- Xun, Ziyu;
- Sang, Xinting;
- Yang, Xiaobo;
- Duan, Weidong;
- Zhao, Haitao
Publication type:
Article
Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed/refractory diffuse large B-cell lymphoma.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03840-0
By:
- Chen, Xinrui;
- Qin, Yan;
- Xue, Xuemin;
- Xie, Zucheng;
- Xie, Tongji;
- Huang, Liling;
- Zhu, Haohua;
- Gao, Lina;
- Li, Jiangtao;
- Yang, Jianliang;
- Gui, Lin;
- Yang, Sheng;
- Chen, Haizhu;
- Feng, Xiaoli;
- Shi, Yuankai
Publication type:
Article
Enhanced anti-tumor efficacy of electroporation (EP)-mediated DNA vaccine boosted by allogeneic lymphocytes in pre-established tumor models.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03838-8
By:
- Shi, Sanyuan;
- Zhang, Luchen;
- Zheng, Anjie;
- Xie, Fang;
- Kesse, Samuel;
- Yang, Yang;
- Peng, Jinliang;
- Xu, Yuhong
Publication type:
Article
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03830-2
By:
- Zhang, Wanli;
- Shi, Xupeiyao;
- Huang, Shitong;
- Yu, Qiumin;
- Wu, Zijie;
- Xie, Wenbin;
- Li, Binghua;
- Xu, Yanchao;
- Gao, Zheng;
- Li, Guozhi;
- Qian, Qianqian;
- He, Tiandi;
- Zheng, Jiaxue;
- Zhang, Tingran;
- Tong, Yue;
- Deng, Danni;
- Gao, Xiangdong;
- Tian, Hong;
- Yao, Wenbing
Publication type:
Article
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03836-w
By:
- De Giglio, Andrea;
- Leonetti, Alessandro;
- Comito, Francesca;
- Filippini, Daria Maria;
- Mollica, Veronica;
- Rihawi, Karim;
- Peroni, Marianna;
- Mazzaschi, Giulia;
- Ricciotti, Ilaria;
- Carosi, Francesca;
- Marchetti, Andrea;
- Rosellini, Matteo;
- Gagliano, Ambrogio;
- Favorito, Valentina;
- Nobili, Elisabetta;
- Gelsomino, Francesco;
- Melotti, Barbara;
- Marchese, Paola Valeria;
- Sperandi, Francesca;
- Di Federico, Alessandro
Publication type:
Article
INTASYL self-delivering RNAi decreases TIGIT expression, enhancing NK cell cytotoxicity: a potential application to increase the efficacy of NK adoptive cell therapy against cancer.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03835-x
By:
- Maxwell, Melissa;
- Yan, Dingxue;
- Rivest, Brianna;
- Boone, Andrew;
- Cardia, James;
- Noessner, Elfriede
Publication type:
Article
PD-L1+ neutrophils induced NETs in malignant ascites is a potential biomarker in HCC.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03833-z
By:
- Sun, Xiaoyu;
- Gui, Yaoqi;
- Yang, Tai;
- Chen, Lingbing;
- Zhang, Yi;
- Yan, Ling;
- Chen, Weixian;
- Wang, Bo
Publication type:
Article
Efficacy and safety of lenvatinib combined with anti-PD-1 antibodies plus GEMOX chemotherapy as non-first-line systemic therapy in advanced gallbladder cancer.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03831-1
By:
- Tan, Yang;
- Liu, Kai;
- Zhu, Chengpei;
- Wang, Shanshan;
- Wang, Yunchao;
- Xue, Jingnan;
- Ning, Cong;
- Zhang, Nan;
- Chao, Jiashuo;
- Zhang, Longhao;
- Long, Junyu;
- Yang, Xiaobo;
- Zeng, Daobing;
- Zhao, Lijin;
- Zhao, Haitao
Publication type:
Article
PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03837-9
By:
- Blobner, Jens;
- Dengler, Laura;
- Eberle, Constantin;
- Herold, Julika J.;
- Xu, Tao;
- Beck, Alexander;
- Mühlbauer, Anton;
- Müller, Katharina J.;
- Teske, Nico;
- Karschnia, Philipp;
- van den Heuvel, Dominic;
- Schallerer, Ferdinand;
- Ishikawa-Ankerhold, Hellen;
- Thon, Niklas;
- Tonn, Joerg-Christian;
- Subklewe, Marion;
- Kobold, Sebastian;
- Harter, Patrick N.;
- Buchholz, Veit R.;
- von Baumgarten, Louisa
Publication type:
Article
A random survival forest-based pathomics signature classifies immunotherapy prognosis and profiles TIME and genomics in ES-SCLC patients.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03829-9
By:
- Jiang, Yuxin;
- Chen, Yueying;
- Cheng, Qinpei;
- Lu, Wanjun;
- Li, Yu;
- Zuo, Xueying;
- Wu, Qiuxia;
- Wang, Xiaoxia;
- Zhang, Fang;
- Wang, Dong;
- Wang, Qin;
- Lv, Tangfeng;
- Song, Yong;
- Zhan, Ping
Publication type:
Article
Tumor immunogenicity regulates host immune responses, and conventional dendritic cell type 2 uptakes the majority of tumor antigens in an orthotopic lung cancer model.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03828-w
By:
- Kim, Ki-Hyun;
- Kim, Seung-jae;
- Eccles, Jacob D.;
- Ascoli, Christian;
- Park, Gye Young
Publication type:
Article
The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03824-0
By:
- Chan, Chilam;
- Cabanes, Núria Casalé;
- Jansen, J. H. Marco;
- Guillaume, Joël;
- Nederend, Maaike;
- Passchier, Elsemieke M.;
- Gómez-Mellado, Valentina E.;
- Peipp, Matthias;
- Boes, Marianne;
- van Tetering, Geert;
- Leusen, Jeanette H. W.
Publication type:
Article
Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03823-1
By:
- Ou, Dan;
- Cai, Rong;
- Qi, Wei-Xiang;
- Cui, Can;
- Cao, Lu;
- Wang, Shu-Bei;
- Li, Huan;
- Ma, Tao;
- Miao, Ying;
- Xu, Cheng;
- Cai, Gang;
- Cao, Wei-Guo;
- Gao, Yun-Sheng;
- Chen, Jia-Yi;
- Xu, Hao-Ping
Publication type:
Article
Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trial.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03815-1
By:
- Sakura, Kazuma;
- Kuroyama, Muneyoshi;
- Shintani, Yasushi;
- Funaki, Soichiro;
- Atagi, Shinji;
- Kadota, Yoshihisa;
- Kuribayashi, Kozo;
- Kijima, Takashi;
- Nakano, Takashi;
- Nakajima, Toshihiro;
- Sasai, Masao;
- Okumura, Meinoshin;
- Kaneda, Yasufumi
Publication type:
Article
Therapeutic antibodies in oncology: an immunopharmacological overview.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03814-2
By:
- Toledo-Stuardo, Karen;
- Ribeiro, Carolina H.;
- González-Herrera, Fabiola;
- Matthies, Douglas J.;
- Le Roy, María Soledad;
- Dietz-Vargas, Claudio;
- Latorre, Yesenia;
- Campos, Ivo;
- Guerra, Yuneisy;
- Tello, Samantha;
- Vásquez-Sáez, Valeria;
- Novoa, Pedro;
- Fehring, Nicolás;
- González, Mauricio;
- Rodríguez-Siza, Jose;
- Vásquez, Gonzalo;
- Méndez, Pamela;
- Altamirano, Claudia;
- Molina, María Carmen
Publication type:
Article
GPCRs: emerging targets for novel T cell immune checkpoint therapy.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03801-7
By:
- Dickinson, Kaitlyn;
- Yee, Elliott J.;
- Vigil, Isaac;
- Schulick, Richard D.;
- Zhu, Yuwen
Publication type:
Article
HLA-G neo-expression modifies genetic programs governing tumor cell lines.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03768-5
By:
- Tronik-Le Roux, Diana;
- Daouya, Marina;
- Poras, Isabelle;
- Desgrandchamps, François;
- Carosella, Edgardo D.
Publication type:
Article

Found: 34

Correction to: Efficacy and safety of anti‑PD‑1/PD‑L1‑based dual immunotherapies versus PD‑1/PD‑L1 inhibitor alone in patients with advanced solid tumor: a systematic review and meta‑analysis.

Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.

Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.

Efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: a systematic review and network meta-analysis.

Efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: a systematic review and network meta-analysis.

Optimizing cancer classification: a hybrid RDO-XGBoost approach for feature selection and predictive insights.

Optimizing cancer classification: a hybrid RDO-XGBoost approach for feature selection and predictive insights.

Integrative analyses of bulk and single-cell RNA-seq reveals the correlation between SPP1<sup>+</sup> macrophages and resistance to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma.

Integrative analyses of bulk and single-cell RNA-seq reveals the correlation between SPP1<sup>+</sup> macrophages and resistance to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma.

Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era.

Correction to: Development of nomograms to predict therapeutic response and prognosis of non-small cell lung cancer patients treated with anti-PD-1 antibody.

Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model.

Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model.

Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era.

Correction to: Development of nomograms to predict therapeutic response and prognosis of non-small cell lung cancer patients treated with anti-PD-1 antibody.

Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget's disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget's disease patients.

Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data.

Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world study.

Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed/refractory diffuse large B-cell lymphoma.

Enhanced anti-tumor efficacy of electroporation (EP)-mediated DNA vaccine boosted by allogeneic lymphocytes in pre-established tumor models.

NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy.

Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy.

INTASYL self-delivering RNAi decreases TIGIT expression, enhancing NK cell cytotoxicity: a potential application to increase the efficacy of NK adoptive cell therapy against cancer.

PD-L1<sup>+</sup> neutrophils induced NETs in malignant ascites is a potential biomarker in HCC.

Efficacy and safety of lenvatinib combined with anti-PD-1 antibodies plus GEMOX chemotherapy as non-first-line systemic therapy in advanced gallbladder cancer.

PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis.

A random survival forest-based pathomics signature classifies immunotherapy prognosis and profiles TIME and genomics in ES-SCLC patients.

Tumor immunogenicity regulates host immune responses, and conventional dendritic cell type 2 uptakes the majority of tumor antigens in an orthotopic lung cancer model.

The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy.

Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial.

Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trial.

Therapeutic antibodies in oncology: an immunopharmacological overview.

GPCRs: emerging targets for novel T cell immune checkpoint therapy.

HLA-G neo-expression modifies genetic programs governing tumor cell lines.